Influence of Eight Unclassified Missense Variants of the MLH1 Gene on Lynch Syndrome Susceptibility

Missense mutations in MLH1 have frequently been detected in patients with Lynch syndrome, but their genetic significance has not been extensively assessed. In this study, we attempt to evaluate the etiological role of eight MLH1 missense variants. The variants were analyzed for their ability to affect MLH1 protein interaction with its partner PMS2 in vivo employing a yeast two-hybrid system. In addition, a SIFT (sorting intolerant from tolerant) algorithm was adopted to predict the effects of amino acid substitutions. Finally, scanning of mutations in a normal Chinese population and assay of the clinical characteristics have all been taken into account. Our results demonstrated that the MLH1 variants D485E and L653R cause functional alterations of the human MutLα complex significantly. The R265C, D304V, A586P, and R755S variants affect partial interaction. The remaining two variants, N38D and L559R, could be nonfunctional polymorphisms or might affect the mismatch repair system through other mechanisms.

[1]  A. Viel,et al.  Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features , 2006, European Journal of Human Genetics.

[2]  J. Jiricny,et al.  Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. , 2002, Gastroenterology.

[3]  P. Peltomäki,et al.  Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. , 1997, Gastroenterology.

[4]  P. Modrich,et al.  Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Z. Hua,et al.  Analysis of hMLH1 Missense Mutations in East Asian Patients with Suspected Hereditary Nonpolyposis Colorectal Cancer , 2007, Clinical Cancer Research.

[6]  A. Cats,et al.  Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. , 1996, American journal of human genetics.

[7]  C. Ishioka,et al.  Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. , 2007, Cancer research.

[8]  M. Loda,et al.  Evaluation of Microsatellite Instability and Updated Version Cited Articles Citing Articles E-mail Alerts Evaluation of Microsatellite Instability and Immunohistochemistry for the Prediction of Germ-line Msh2 and Mlh1 Mutations in Hereditary Nonpolyposis Colon Cancer Families , 2022 .

[9]  Xiao-mei Zhang,et al.  Variations in exon 7 of the MSH2 gene and susceptibility to gastrointestinal cancer in a Chinese population. , 2006, Cancer genetics and cytogenetics.

[10]  R. Scott,et al.  Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. , 2001, American journal of human genetics.

[11]  J. Jiricny,et al.  hMutSβ, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA , 1996, Current Biology.

[12]  A. Ellison,et al.  Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae. , 2001, Human molecular genetics.

[13]  D. Aust,et al.  Identification of six novel MSH2 and MLH1 germline mutations in HNPCC , 2003, Human mutation.

[14]  A. Lindblom,et al.  Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and hMLH1. , 1999, Genetic testing.

[15]  R. Fishel,et al.  The Interaction of the Human MutL Homologues in Hereditary Nonpolyposis Colon Cancer* , 1999, The Journal of Biological Chemistry.

[16]  G. Taylor,et al.  Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non‐polyposis colorectal cancer: Identification of novel and recurrent deletions by MLPA , 2003, Human mutation.

[17]  J. Stockman Conversion Analysis for Mutation Detection in MLH1 and MSH2 in Patients With Colorectal Cancer , 2006 .

[18]  C. Ban,et al.  Crystal Structure and ATPase Activity of MutL Implications for DNA Repair and Mutagenesis , 1998, Cell.

[19]  M. D'urso,et al.  Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer , 2002, Genes, chromosomes & cancer.

[20]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[21]  J. Garber,et al.  Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. , 1999, JAMA.

[22]  Hideyuki Suzuki,et al.  A yeast two-hybrid assay provides a simple way to evaluate the vast majority of hMLH1 germ-line mutations. , 2003, Cancer research.

[23]  E. Alani,et al.  The effect of genetic background on the function of Saccharomyces cerevisiae mlh1 alleles that correspond to HNPCC missense mutations. , 2007, Human molecular genetics.

[24]  Xiao-mei Zhang,et al.  Germline mutations and polymorphic variants in MMR, E‐cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China , 2006, International journal of cancer.

[25]  J. Tazi,et al.  A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects , 2008, Human mutation.

[26]  A. Horii,et al.  The interacting domains of three MutL heterodimers in man: hMLH1 interacts with 36 homologous amino acid residues within hMLH3, hPMS1 and hPMS2. , 2001, Nucleic acids research.

[27]  R. Scott,et al.  Influence of selection criteria on mutation detection in patients with hereditary nonpolyposis colorectal cancer , 1999, Cancer.

[28]  C. Simone,et al.  Mutational germline analysis of hMSH2 andhMLH1 genes in early onset colorectal cancer patients , 2000, Journal of medical genetics.

[29]  P. Modrich,et al.  Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. , 1995, Science.